$6.08
-0.46-7.03%
Pre-Market: 9:11 AM EDT
15 minutes delayed
Fennec Pharmaceuticals
FENCNASDAQ
want to know what
the Bulls & Bears Say?
Fennec Pharmaceuticals (NASDAQ:FENC) Stock, Analyst Ratings, Price Targets, Forecasts
Fennec Pharmaceuticals Inc has a consensus price target of $15 based on the ratings of 6 analysts. The high is $19 issued by Wedbush on September 26, 2022. The low is $11 issued by Capital One on September 7, 2022. The 3 most-recent analyst ratings were released by Craig-Hallum, HC Wainwright & Co., and HC Wainwright & Co. on May 15, 2024, May 15, 2024, and April 4, 2024, respectively. With an average price target of $16.67 between Craig-Hallum, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 174.12% upside for Fennec Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Craig-Hallum
HC Wainwright & Co.
Cantor Fitzgerald
Cantor Fitzgerald
Wedbush
1calculated from analyst ratings
Analyst Ratings for Fennec Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2024 | Buy Now | 179.61% | Craig-Hallum | Chase Knickerbocker | $20 → $17 | Maintains | Buy | Get Alert |
| 05/15/2024 | Buy Now | 146.71% | HC Wainwright & Co. | Raghuram Selvaraju | $18 → $15 | Maintains | Buy | Get Alert |
| 04/04/2024 | Buy Now | 196.05% | HC Wainwright & Co. | Raghuram Selvaraju | $17 → $18 | Maintains | Buy | Get Alert |
| 03/18/2024 | Buy Now | 196.05% | Craig-Hallum | Chase Knickerbocker | $17 → $18 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | 179.61% | HC Wainwright & Co. | Raghuram Selvaraju | $18 → $17 | Maintains | Buy | Get Alert |
| 06/21/2023 | Buy Now | 196.05% | HC Wainwright & Co. | Raghuram Selvaraju | → $18 | Reiterates | Buy → Buy | Get Alert |
| 04/06/2023 | Buy Now | 163.16% | Cantor Fitzgerald | Charles Robertson II | $12 → $16 | Maintains | Overweight | Get Alert |
| 04/04/2023 | Buy Now | 196.05% | HC Wainwright & Co. | Raghuram Selvaraju | → $18 | Reiterates | → Buy | Get Alert |
| 03/31/2023 | Buy Now | 196.05% | HC Wainwright & Co. | Raghuram Selvaraju | → $18 | Reiterates | → Buy | Get Alert |
| 01/26/2023 | Buy Now | 196.05% | HC Wainwright & Co. | Raghuram Selvaraju | → $18 | Reiterates | → Buy | Get Alert |
| 11/22/2022 | Buy Now | 97.37% | Cantor Fitzgerald | Charles Duncan | $9 → $12 | Upgrade | Neutral → Overweight | Get Alert |
| 10/20/2022 | Buy Now | 196.05% | HC Wainwright & Co. | Raghuram Selvaraju | $14 → $18 | Maintains | Buy | Get Alert |
| 09/26/2022 | Buy Now | 212.5% | Wedbush | David Nierengarten | $11 → $19 | Maintains | Outperform | Get Alert |
| 09/07/2022 | Buy Now | 80.92% | Capital One | Naureen Quibria | → $11 | Initiates | → Overweight | Get Alert |
| 08/08/2022 | Buy Now | 130.26% | Craig-Hallum | Chase Knickerbocker | → $14 | Assumes | → Buy | Get Alert |
FAQ
What is the target price for Fennec Pharmaceuticals (FENC) stock?
The latest price target for Fennec Pharmaceuticals (NASDAQ:FENC) was reported by Craig-Hallum on May 15, 2024. The analyst firm set a price target for $17.00 expecting FENC to rise to within 12 months (a possible 179.61% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fennec Pharmaceuticals (FENC)?
The latest analyst rating for Fennec Pharmaceuticals (NASDAQ:FENC) was provided by Craig-Hallum, and Fennec Pharmaceuticals maintained their buy rating.
When was the last upgrade for Fennec Pharmaceuticals (FENC)?
The last upgrade for Fennec Pharmaceuticals Inc happened on November 22, 2022 when Cantor Fitzgerald raised their price target to $12. Cantor Fitzgerald previously had a neutral for Fennec Pharmaceuticals Inc.
When was the last downgrade for Fennec Pharmaceuticals (FENC)?
There is no last downgrade for Fennec Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Fennec Pharmaceuticals (FENC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fennec Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fennec Pharmaceuticals was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
Is the Analyst Rating Fennec Pharmaceuticals (FENC) correct?
While ratings are subjective and will change, the latest Fennec Pharmaceuticals (FENC) rating was a maintained with a price target of $20.00 to $17.00. The current price Fennec Pharmaceuticals (FENC) is trading at is $6.08, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.